Progress in the correlation between PTPN12 gene expression and human tumors.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Cancer morbidity is increasing globally despite therapeutic advancements.
• Protein tyrosine phosphatase non-receptor type 12 (PTPN12) is identified as a cytoplasmic protein tyrosine phosphatase.
• No prior studies have comprehensively reviewed PTPN12 gene expression in human tumors.

Purpose of the Study:

• To review current research on the relationship between PTPN12 gene expression and human tumors.
• To explore the role of PTPN12 in tumorigenesis.

Main Methods:

• Systematic literature review of domestic and international research.
• Searches conducted in Web of Science and PubMed.
• Keywords included PTPN12, tumor, renal cell carcinoma, proto-oncogenes, and tumor suppressor genes.

Main Results:

• Tumors are characterized by a genetic imbalance between proto-oncogenes and tumor suppressor genes.
• PTPN12 is identified as a tumor suppressor gene.
• Inhibition of PTPN12 activity contributes to tumor occurrence.

Conclusions:

• PTPN12 is a tumor suppressor gene with implications for cancer etiology.
• PTPN12 may serve as a future molecular marker for cancer patients.
• Developing agents to activate tumor suppressor genes like PTPN12 presents a promising research avenue.